Aug 12, 2026 04:07PM
Aug 12, 2026 04:02PM
Aug 10, 2026 08:00AM
Jul 28, 2026 06:44AM
May 13, 2026 04:19PM
May 13, 2026 04:11PM
May 13, 2026 04:02PM Omeros Corporation Reports First Quarter 2026 Financial Results
May 11, 2026 04:02PM
Mar 31, 2026 04:10PM
Mar 31, 2026 04:02PM
Mar 26, 2026 08:45AM
Nov 13, 2025 04:17PM
Nov 13, 2025 04:11PM
Nov 11, 2025 08:30AM Omeros Corporation to Announce Third Quarter Financial Results on November 13, 2025
Aug 14, 2025 04:03PM
Aug 14, 2025 04:02PM
Aug 11, 2025 04:02PM
May 15, 2025 04:09PM
May 15, 2025 04:05PM
May 12, 2025 05:05PM
Mar 31, 2025 04:03PM Omeros (OMER) Tops Q4 EPS by 15c
Mar 31, 2025 04:02PM
Mar 26, 2025 09:15AM
Nov 21, 2024 09:15AM
Nov 21, 2024 09:15AM
Nov 13, 2024 04:04PM
Nov 13, 2024 04:02PM
Nov 11, 2024 04:11PM Omeros Corporation to Announce Third Quarter Financial Results on November 13, 2024
Aug 7, 2024 04:37PM
Aug 7, 2024 04:02PM
Aug 5, 2024 04:02PM
May 15, 2024 04:04PM
May 15, 2024 04:02PM
May 10, 2024 08:50AM
Apr 1, 2024 04:02PM Omeros Corporation Reports Fourth Quarter and Year-End 2023 Financial Results
Mar 27, 2024 08:30AM
Nov 9, 2023 04:29PM
Nov 9, 2023 04:02PM
Nov 6, 2023 08:00AM
Aug 9, 2023 08:08AM
Aug 9, 2023 08:00AM
Aug 4, 2023 08:00AM Omeros Corporation to Announce Second Quarter Financial Results on Morning of August 9, 2023
May 9, 2023 04:31PM
May 9, 2023 04:02PM
May 4, 2023 04:06PM
Mar 13, 2023 04:02PM
Mar 7, 2023 09:00AM
Nov 9, 2022 04:02PM
Nov 8, 2022 08:36AM Omeros (OMER) Receives Decision from FDA on Formal Dispute Resolution Request for Narsoplimab
Nov 8, 2022 08:30AM

1,218,679 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All